BioCentury
ARTICLE | Clinical News

Rasitrio aliskiren/amlodipine/hydrochlorothiazide regulatory update

December 5, 2011 8:00 AM UTC

The European Commission approved Rasitrio aliskiren/amlodipine/hydrochlorothiazide from Novartis to treat high blood pressure. Rasitrio is a single pill combination of aliskiren, amlodipine and hydroc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article